Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joe Lutzky"'
Autor:
Sandra Aung, Sigrun Hallmeyer, David F. McDermott, Joseph I. Clark, Howard L. Kaufman, Gregory A. Daniels, Sapna P. Patel, John M. Kirkwood, Ryan J. Sullivan, Marc S. Ernstoff, Brendan D. Curti, Elizabeth I. Buchbinder, Rene Gonzalez, John M. Richart, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Girald P. Miletello, Joe Lutzky, Michael A. Morse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Background High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However
Externí odkaz:
https://doaj.org/article/44e74afcb6e54cb58b9c7f23eb3b71b5
Autor:
Gregory A. Daniels, John M. Richart, Elizabeth I. Buchbinder, Jessica C. Perritt, John M. Kirkwood, Marc S. Ernstoff, Howard L. Kaufman, David F. McDermott, Michael A. Morse, Sigrun Hallmeyer, Anasuya Gunturi, Girald P. Miletello, Brendan D. Curti, Sandra Aung, Janice P. Dutcher, Ryan J. Sullivan, Rene Gonzalez, Sapna Pradyuman Patel, Joseph I. Clark, Joe Lutzky
Publikováno v:
Journal for Immunotherapy of Cancer
Background High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75cd011505d6f7f0c20e345409b37a3
https://doi.org/10.1186/s40425-016-0155-8
https://doi.org/10.1186/s40425-016-0155-8